Correlation Between Structure Therapeutics and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Structure Therapeutics and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Crinetics Pharmaceuticals.
Diversification Opportunities for Structure Therapeutics and Crinetics Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Structure and Crinetics is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the Crinetics Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Structure Therapeutics American is 1.12 times less risky than Crinetics Pharmaceuticals. The stock trades about -0.22 of its potential returns per unit of risk. The Crinetics Pharmaceuticals is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 3,376 in Crinetics Pharmaceuticals on May 2, 2025 and sell it today you would lose (517.00) from holding Crinetics Pharmaceuticals or give up 15.31% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Structure Therapeutics America vs. Crinetics Pharmaceuticals
Performance |
Timeline |
Structure Therapeutics |
Crinetics Pharmaceuticals |
Structure Therapeutics and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Structure Therapeutics and Crinetics Pharmaceuticals
The main advantage of trading using opposite Structure Therapeutics and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.Structure Therapeutics vs. Terns Pharmaceuticals | Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. Acumen Pharmaceuticals | Structure Therapeutics vs. Amylyx Pharmaceuticals |
Crinetics Pharmaceuticals vs. Ideaya Biosciences | Crinetics Pharmaceuticals vs. AnaptysBio | Crinetics Pharmaceuticals vs. MeiraGTx Holdings PLC | Crinetics Pharmaceuticals vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |